Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques
- 1 July 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 90 (3) , 619-624
- https://doi.org/10.1111/j.1365-2141.1995.tb05593.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Karyotype in multiple myeloma and plasma cell leukaemiaEuropean Journal Of Cancer, 1993
- Similar cytogenetic abnormalities in two cases of plasma cell leukemiaCancer Genetics and Cytogenetics, 1991
- Interleukin-6 is a cofactor for the growth of myeloid cells from human bone marrow aspirates but does not affect the clonogenicity of myeloma cells in vitroBritish Journal of Haematology, 1990
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989
- Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6Blood, 1989
- Plasma cell karyotype in multiple myelomaBlood, 1988
- The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosisBlood, 1985
- High incidence of chromosome abnormalities in IgG3 myelomaCancer Genetics and Cytogenetics, 1984
- Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disordersCancer, 1979
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975